Autologous haematopoietic stem cell transplantation (HSCT) is the only treatment that is
able to induce long-term, drug-free and symptom-free remission in several refractory …

Recent therapeutic advances in juvenile idiopathic arthritis (JIA) have made remission an
achievable goal for most patients. Reaching this target leads to improved outcomes. The …

Objective The clinical impact of anti-drug antibodies (ADAbs) in paediatric patients with JIA
remains unknown. This systematic review and meta-analysis aimed to summarize the …

The translation of basic insight in immunological mechanisms underlying inflammation into
clinical practice of inflammatory diseases is still challenging. Here we describe how—through …

Objective Children with juvenile idiopathic arthritis (JIA) experience functional impairment
due to joint manifestations of the disease. The aim of our present study was to assess health‐…

Context Since the introduction of biologic therapies, the pharmacological treatment approach
for juvenile idiopathic arthritis (JIA) has changed substantially, with achievement of inactive …

Objective Systemic juvenile idiopathic arthritis (JIA) is a multifactorial autoinflammatory disease
with a historically poor prognosis. With current treatment regimens, approximately half of …

Background To our knowledge, the characteristics and burden of childhood arthritis have
never been studied on a worldwide basis. We aimed to investigate, with a cross-sectional study…

Objectives To assess if the Juvenile Arthritis Disease Activity Score (JADAS71) could be
used to correctly identify patients with juvenile idiopathic arthritis (JIA) in need of antitumour …

… Notably, the new cutoffs are closer to the JADAS thresholds identified by Swart et al for
treatment escalation from a cohort of JIA patients seen at an academic center (28). …